Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats

Bone

Volumn 47, Issue 3, 2010, Pages 480-492

  Komrakova, Marina ^a   Stuermer, Ewa K ^a   Werner, Carsten ^b   Wicke, Michael ^a   Kolios, Leila ^a   Sehmisch, Stephan ^a   Tezval, Mohammad ^a   Daub, Florian ^a   Martens, Timo ^a   Witzenhausen, Peter ^a   Dullin, Christian ^a   Stuermer, Klaus M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Institute of Food Quality and Safety   (Germany)

Author keywords

Fracture healing; Intermittent parathyroid hormone; Muscle; Osteoporosis; Ovariectomized rat

Indexed keywords

ESTRADIOL BENZOATE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE[1-34];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALLUS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FRACTURE HEALING; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; MITOCHONDRIAL RESPIRATION; MORPHOMETRICS; MUSCLE CELL; MUSCLE MASS; NONHUMAN; OVARIECTOMY; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; RAT; SINGLE DRUG DOSE; TIBIA OSTEOTOMY; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURE HEALING; HUMANS; MUSCLE, SKELETAL; ORGAN SIZE; OSTEOTOMY; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TERIPARATIDE; TIBIA;

EID: 77955845913     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.05.013     Document Type: Article

References (39)

1. Barnes G.L., Kakar S., Vora S., Morgan E.F., Gerstenfeld L.C., Einhorn T.A. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J. Bone Joint Surg. Am. 2008, 90(Suppl 1):120-127.
2. Hodsman A.B., Bauer D.C., Dempster D.W., et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr. Rev. 2005, 26:688-703.
3. Alkhiary Y.M., Gerstenfeld L.C., Krall E., et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). Bone Joint Surg Am 2005, 87:731-741.
4. Nakazawa T., Nakajima A., Shiomi K., Moriya H., Einhorn T.A., Yamazaki M. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 2005, 37:711-719.
5. Jahng J.S., Kim H.W. Effect of intermittent administration of parathyroid hormone on fractures healing in ovariectomized rats. Orthopedics 2000, 23:1089-1094.
6. Andreassen T.T., Fledelius C., Ejersted C., Oxlund H. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop. Scand. 2001, 72:304-307.
7. Namkung-Matthai H., Appleyard R., Jansen J., et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 2001, 28(1):80-86.
8. Yingjie H., Ge Z., Yisheng W., et al. Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 2007, 41:631-638.
9. Nozaka K., Miyakoshi N., Kasukawa Y., Maekawa S., Noguchi H., Shimada Y. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 2008, 42:90-97.
10. Nakajima A., Shimoji N., Shiomi K., et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J. Bone Miner. Res. 2002, 17:2038-2047.
11. Shin R., Stern G. Myopathy, osteomalacia and hyperparathyroidism. Brain 1967, 90:593-602.
12. Baczynski R., Massry S.G., Magott M., El-Belbessi S., Kohan R., Brautbar N. Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int. 1985, 28:722-727.
13. Visser M., Deeg D.J.H., Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J. Clin. Endocrinol. Metab. 2003, 88:5766-5772.
14. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991, 15:175-192.
15. Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-Wuttke D, Tezval M, Wuttke W, Frosch KH, Stuermer KM. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat. Langenbecks Arch Surg 2010;395:163-172.
16. Liu C.C., Kalu D.N. Human PTH prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J. Bone Miner. Res. 1990, 3:973-982.
17. Vortherms T. Effects of daidzein, its metabolite equol, puerarin, quercetin and estradiol on the pituitary and the urogenital tract of the ovariectomized rats. Dissertation Hannover, 2006;126 p. (). http://deposit.d-nb.de/cgi-bin/dokserv?idn=98363615x&dok_var=d1&dok_ext=pdf&filename=98363615x.pdf.
18. Komrakova M., Werner C., Wicke M., et al. Effect of daidzein, 4-Methylbenzylidene camphor or estrogen on gastrocnemius muscle of osteoporotic rats undergoing tibia healing period. J. Endocrinol. 2009, 201:253-262.
19. Rahn D.A. The fluorochrome sequence labelling of the bone. Nova Acta Leopold 1976, 44:249-255.
20. Missbach-Guentner J., Dullin C., Zientkowska M., et al. Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model. Neoplasia 2007, 9:755-765.
21. Stürmer E.K., Seidlová-Wuttke D., Sehmisch S., et al. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J. Bone Miner. Res. 2006, 21:89-96.
22. Parfitt A.M., Drezner M.K., Glorieux F.H., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J. Bone Miner. Res. 1987, 2(6):595-610.
23. Sehmisch S, Galal R, Kolios L, Tezval M, Dullin C, Zimmer S, Stuermer KM, Stuermer EK. Effects of low-magnitude, high-frequency mechanical stimulation in the rat osteopenia model. Osteoporosis Int 2009;20:1999-2000.
24. Seidlová-Wuttke D., Stuermer K.M., Stuermer E.K., Sehmisch S., Wuttke W. Contrasting effects of estradiol, testosterone and of black cohosh extract on density, mechanical properties and expression of several genes in the metaphysic of the tibia and on fat tissue of orchidectomized rats. Maturitas 2006, 55:S64-S74.
25. -δδCT method. Methods 2001, 25:402-408.
26. Peter J.B., Barnard R.J., Edgerton V.R., Gillespie C.A., Stempel K.E. Metabolic profiles of the three fiber types of skeletal muscle in guinea pigs and rabbits. Biochemistry 1972, 11:2627-2633.
27. Shirota T., Tashiro M., Ohno K., Yamaguchi A. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. J. Oral Maxillofac. Surg. 2003, 61:471-480.
28. Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., Pak C.Y. Severely suppressed bone turnover, a potential complication of alendronate therapy. J. Clin. Endocrinol. Metab. 2005, 90:1294-1301.
29. Kolios L., Sehmisch S., Daub F., et al. Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats. Planta Med. 2009, 75(5):459-465. Epub 2009 Feb 24.
30. Kolios L, Hoerster AK, Sehmisch S, Malcherek MC, Rack T, Tezval M, Seidlova-Wuttke D, Wuttke W, Stuermer KM, Stuermer EK. Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis? Calcif Tissue Int 2010;86:23-32.
31. Shen V., Dempster D.W., Mellish R.W.E., Birchman R., Horbert W., Lindsay R. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia. Calcif. Tissue Int. 1992, 50:214-220.
32. Dobnig H., Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 1997, 138:4607-4612.
33. Meyer R.A., Meyer M.H., Tenholder M., Wondracek S., Wasserman R., Garges P. Gene expression in older rats with delayed union of femoral fractures. J. Bone Joint Surg. 2003, 85A(7):1243-1254.
34. Kon T., Cho T., Aizawa T., et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J. Bone Miner. Res. 2001, 16:1004-1014.
35. Kobori M., Yamamuro T. Effects of gonadectomy and estrogen administration on rat skeletal muscle. Clin. Orthop. 1989, 243:306-311.
36. Palmieri G.M.A., Nutting D.F., Bhattacharya S.K., Bernstein T.E., Williams J.C. Parathyroid ablation in dystrophic hamsters. Effect of Ca content and histology of heart, diaphragm and rectus femoris. J. Clin. Invest. 1982, 68:646-654.
37. Joborn C., Joborn H., Rastad J., Akerstrom G., Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br. J. Surg. 1988, 75:77-80.
38. Bolland M.J., Grey A.B., Ames R.W., Horne A.M., Gamble G.D., Reid I.R. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 2006, 38:317-321.
39. Berg B.N., Harmison C.R. Growth, disease, and aging in the rat. J. Gerontol. 1957, 2:370-377.